학술논문
253rd ENMC international workshop: Striated muscle laminopathies - natural history and clinical trial readiness. 24-26 June 2022, Hoofddorp, the Netherlands.
Document Type
Conference
Author
Maggi L; Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Instituto Neurologico Carlo Besta, Milano, Italy. Electronic address: lorenzo.Maggi@istituto-besta.it.; Quijano-Roy S; APHP-Université Paris-Saclay, Neuromuscular Disorders Reference Center of Nord-Est-Île de France, FILNEMUS, ERN-Euro-NMD, Creteil, France; Pediatric Neurology and ICU Department, DMU Santé Enfant Adolescent (SEA), Raymond Poincaré University Hospital, Garches, France.; Bönnemann C; Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.; Bonne G; Sorbonne Université, INSERM, Institut de Myologie, Centre de Recherche en Myologie, Paris, France. Electronic address: g.bonne@institut-myologie.org.
Source
Publisher: Pergamon Press Country of Publication: England NLM ID: 9111470 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2364 (Electronic) Linking ISSN: 09608966 NLM ISO Abbreviation: Neuromuscul Disord Subsets: MEDLINE
Subject
Language
English
Abstract
Competing Interests: Declaration of Competing Interest Dr. Maggi has received honoraria for speaking, advisory boards and compensation for congress participations from Sanofi Genzyme, Roche and Biogen, Amicus Therapeutics, Alexion, Janssen, Lupin, outside the submitted work. Dr. D'Amico has received honoraria as consultant in scientific advisory boards and for sponsored lectures form PTC therapeutics Roche, Avexis, Sanofi-Genzyme and Biogen outside the submitted work. Dr. Bonanno has received honoraria for speaking, advisory boards and compensation for congress participations from Biogen, Roche, Alexion and Sanofi Genzyme. Dr Andrés Nascimento has received honoraria for speaking, advisory boards and compensation for congress participations from Sanofi Genzyme, Roche, Sarepta, PTC therapeutics, Biogen, SRK, and Novartis.